Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Coates

Showing results (101-110 of 150) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancerS Gelber, A S Coates, A Goldhirsch, et al.
Statistics in Medicine|April 29, 1998
Missing quality of life data in cancer clinical trials: serious problems and challengesJ Bernhard, D F Cella, A S Coates, et al.
Journal of the American College of Surgeons|December 1, 1995
Elective lymph node dissectionA S Coates, C I Ingvar, K Petersen-Schaefer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 1997
Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study GroupJ Bernhard, C Hürny, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Routine tests during follow-up of patients after primary treatment for operable breast cancer. International (Ludwig) Breast Cancer Study Group (IBCSG)D Crivellari, K N Price, M Hagen, et al.
Lancet (London, England)|January 8, 2008
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials, M Clarke, A S Coates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials GroupM J Byrne, V Gebski, J Forbes, et al.
BMJ (Clinical Research Ed.)|February 4, 1989
Changing character of cervical cancer in young womenP M Elliott, M H Tattersall, M Coppleson, et al.
ANZ Journal of Surgery|February 13, 2001
Tubular carcinoma of the breast: prognosis and response to adjuvant systemic therapyP R Kitchen, T H Smith, M A Henderson, et al.
Melanoma Research|April 1, 1993
Interferon-alpha 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: results of a multi-institutional Australian randomized trialD B Thomson, M Adena, G R McLeod, et al.
Pageof 15

Showing results (101-110 of 150) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancerS Gelber, A S Coates, A Goldhirsch, et al.
Statistics in Medicine|April 29, 1998
Missing quality of life data in cancer clinical trials: serious problems and challengesJ Bernhard, D F Cella, A S Coates, et al.
Journal of the American College of Surgeons|December 1, 1995
Elective lymph node dissectionA S Coates, C I Ingvar, K Petersen-Schaefer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 1997
Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study GroupJ Bernhard, C Hürny, A S Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Routine tests during follow-up of patients after primary treatment for operable breast cancer. International (Ludwig) Breast Cancer Study Group (IBCSG)D Crivellari, K N Price, M Hagen, et al.
Lancet (London, England)|January 8, 2008
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials, M Clarke, A S Coates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials GroupM J Byrne, V Gebski, J Forbes, et al.
BMJ (Clinical Research Ed.)|February 4, 1989
Changing character of cervical cancer in young womenP M Elliott, M H Tattersall, M Coppleson, et al.
ANZ Journal of Surgery|February 13, 2001
Tubular carcinoma of the breast: prognosis and response to adjuvant systemic therapyP R Kitchen, T H Smith, M A Henderson, et al.
Melanoma Research|April 1, 1993
Interferon-alpha 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: results of a multi-institutional Australian randomized trialD B Thomson, M Adena, G R McLeod, et al.
Pageof 15